Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wirth

Showing results (631-640 of 675) with videos related to

Pageof 68
Sort By:
World Journal of Urology|June 9, 2016
HER2 overexpression is associated with worse outcomes in patients with upper tract urothelial carcinoma (UTUC)Francesco Soria, Marco Moschini, Andrea Haitel, et al.
The Journal of Clinical Endocrinology and Metabolism|May 19, 2021
Afirma Genomic Sequencing Classifier and Xpression Atlas Molecular Findings in Consecutive Bethesda III-VI Thyroid NodulesMimi I Hu, Steven G Waguespack, Chrysoula Dosiou, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 21, 2009
Assessment of trabecular and cortical architecture and mechanical competence of bone by high-resolution peripheral computed tomography: comparison with transiliac bone biopsyA Cohen, D W Dempster, R Müller, et al.
The Oncologist|March 31, 2019
Clinically Integrated Molecular Diagnostics in Adenoid Cystic CarcinomaJulia Thierauf, Nisha Ramamurthy, Vickie Y Jo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2013
Cabozantinib in progressive medullary thyroid cancerRossella Elisei, Martin J Schlumberger, Stefan P Müller, et al.
The Journal of Clinical Endocrinology and Metabolism|August 12, 2011
Abnormal bone microarchitecture and evidence of osteoblast dysfunction in premenopausal women with idiopathic osteoporosisAdi Cohen, David W Dempster, Robert R Recker, et al.
Thyroid : Official Journal of the American Thyroid Association|August 19, 2025
Patient-Reported Tolerability of Selpercatinib Compared to Cabozantinib/Vandetanib: A Secondary Analysis of the LIBRETTO-531 Randomized-Controlled Trial in <i>RET</i>-Mutant Medullary Thyroid CancerRossella Elisei, Lori J Wirth, Jaume Capdevila, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 29, 2012
Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatmentValentina Nardi, Peter M Sadow, Dejan Juric, et al.
Cancer Research|May 21, 2013
Metformin decreases glucose oxidation and increases the dependency of prostate cancer cells on reductive glutamine metabolismSarah-Maria Fendt, Eric L Bell, Mark A Keibler, et al.
The New England Journal of Medicine|February 12, 2015
Lenvatinib versus placebo in radioiodine-refractory thyroid cancerMartin Schlumberger, Makoto Tahara, Lori J Wirth, et al.
Pageof 68

Showing results (631-640 of 675) with videos related to

Sort By:
Pageof 68
World Journal of Urology|June 9, 2016
HER2 overexpression is associated with worse outcomes in patients with upper tract urothelial carcinoma (UTUC)Francesco Soria, Marco Moschini, Andrea Haitel, et al.
The Journal of Clinical Endocrinology and Metabolism|May 19, 2021
Afirma Genomic Sequencing Classifier and Xpression Atlas Molecular Findings in Consecutive Bethesda III-VI Thyroid NodulesMimi I Hu, Steven G Waguespack, Chrysoula Dosiou, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 21, 2009
Assessment of trabecular and cortical architecture and mechanical competence of bone by high-resolution peripheral computed tomography: comparison with transiliac bone biopsyA Cohen, D W Dempster, R Müller, et al.
The Oncologist|March 31, 2019
Clinically Integrated Molecular Diagnostics in Adenoid Cystic CarcinomaJulia Thierauf, Nisha Ramamurthy, Vickie Y Jo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2013
Cabozantinib in progressive medullary thyroid cancerRossella Elisei, Martin J Schlumberger, Stefan P Müller, et al.
The Journal of Clinical Endocrinology and Metabolism|August 12, 2011
Abnormal bone microarchitecture and evidence of osteoblast dysfunction in premenopausal women with idiopathic osteoporosisAdi Cohen, David W Dempster, Robert R Recker, et al.
Thyroid : Official Journal of the American Thyroid Association|August 19, 2025
Patient-Reported Tolerability of Selpercatinib Compared to Cabozantinib/Vandetanib: A Secondary Analysis of the LIBRETTO-531 Randomized-Controlled Trial in <i>RET</i>-Mutant Medullary Thyroid CancerRossella Elisei, Lori J Wirth, Jaume Capdevila, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 29, 2012
Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatmentValentina Nardi, Peter M Sadow, Dejan Juric, et al.
Cancer Research|May 21, 2013
Metformin decreases glucose oxidation and increases the dependency of prostate cancer cells on reductive glutamine metabolismSarah-Maria Fendt, Eric L Bell, Mark A Keibler, et al.
The New England Journal of Medicine|February 12, 2015
Lenvatinib versus placebo in radioiodine-refractory thyroid cancerMartin Schlumberger, Makoto Tahara, Lori J Wirth, et al.
Pageof 68